Published in Cancer Res on October 01, 1985
Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis. Clin Cancer Res (2015) 1.42
Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression. Clin Cancer Res (2009) 1.04
Bladder cancer cell line cross-contamination: identification using a locus-specific minisatellite probe. Br J Cancer (1988) 0.97
Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1987) 0.96
ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors. PLoS One (2013) 0.91
The use of short tandem repeat profiling to characterize human bladder cancer cell lines. J Urol (2009) 0.91
Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres. Proc Natl Acad Sci U S A (1991) 0.88
Clinical relevance of maspin expression in bladder cancer. World J Urol (2006) 0.82
Ultrastructure and dynamics of selective mitochondrial injury in carcinoma cells after doxycycline photosensitization in vitro. Am J Pathol (1988) 0.80
Fibroblast growth factor receptor 3 interacts with and activates TGFβ-activated kinase 1 tyrosine phosphorylation and NFκB signaling in multiple myeloma and bladder cancer. PLoS One (2014) 0.80
Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity. Br J Cancer (1990) 0.77
The combined effects of high-energy shock waves and cytostatic drugs or cytokines on human bladder cancer cells. Br J Cancer (1994) 0.75
The expression sequence tag is an effective method for screening DNA segments that predict urinary bladder transitional cell carcinoma prognosis. Onco Targets Ther (2014) 0.75
Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg (1966) 3.06
The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. J Virol (1989) 2.65
Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A (1983) 2.54
Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia (2006) 2.53
Structural determinants for transcriptional activation by cAMP-responsive DNA elements. J Biol Chem (1988) 1.93
Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol (1991) 1.91
Elimination of the slow gating of ClC-0 chloride channel by a point mutation. J Gen Physiol (1999) 1.89
Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus. J Virol (1984) 1.88
Correlation of trabecular bone structure with age, bone mineral density, and osteoporotic status: in vivo studies in the distal radius using high resolution magnetic resonance imaging. J Bone Miner Res (1997) 1.86
The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent. J Virol (1989) 1.86
Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA. Virology (1979) 1.80
Report of an IEEE task force--an IEEE opinion on research needs for biomedical engineering systems. IEEE Trans Biomed Eng (1986) 1.77
Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol (1991) 1.57
Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. Exp Cell Res (2001) 1.54
Functional mutation in the promoter region of thrombomodulin gene in relation to carotid atherosclerosis. Atherosclerosis (2001) 1.45
The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder. J Urol (1981) 1.44
Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol (1976) 1.41
Vascular dementia of Binswanger's type: clinical, neuroradiological and 99mTc-HMPAO SPET study. Eur J Nucl Med (1996) 1.40
Panencephalitic Creutzfeldt-Jakob disease. Unusual presentation of magnetic resonance imaging and proton magnetic resonance spectroscopy. J Neurol Sci (1996) 1.38
Response of men with advanced prostatic carcinoma to exogenous administration of testosterone. Cancer (1967) 1.38
A new mode of percutaneous upper thoracic phenol sympathicolysis: report of 50 cases. Neurosurgery (2001) 1.37
Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent. DNA Cell Biol (1998) 1.34
Some urological aspects of 93 consecutive renal homotransplants in modified recipients. J Urol (1967) 1.32
Trabecular bone architecture in the distal radius using magnetic resonance imaging in subjects with fractures of the proximal femur. Magnetic Resonance Science Center and Osteoporosis and Arthritis Research Group. Osteoporos Int (1999) 1.30
Impact of spatial resolution on the prediction of trabecular architecture parameters. Bone (1998) 1.26
A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg (1976) 1.26
Proton radiation as boost therapy for localized prostatic carcinoma. JAMA (1979) 1.25
Ta and T1 bladder cancer: location, recurrence and progression. Br J Urol (1982) 1.24
In vivo high resolution MRI of the calcaneus: differences in trabecular structure in osteoporosis patients. J Bone Miner Res (1998) 1.23
Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res (1986) 1.22
Keratin 10 gene expression during differentiation of mouse epidermis requires transcription factors C/EBP and AP-2. Dev Biol (1999) 1.22
Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J Clin Microbiol (1999) 1.22
Carcinoma of the prostate and lymphatic metastases. J Urol (1974) 1.21
High-resolution magnetic resonance imaging: three-dimensional trabecular bone architecture and biomechanical properties. Bone (1998) 1.21
Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody. J Virol (1985) 1.20
Identification of two molecular forms of (Na+,K+)-ATPase in rat adipocytes. Relation to insulin stimulation of the enzyme. J Biol Chem (1985) 1.19
Epstein-Barr virus: inhibition of replication by three new drugs. Science (1983) 1.17
L-Homoarginine. An organ-specific, uncompetitive inhibitor of human liver and bone alkaline phosphohydrolases. J Biol Chem (1972) 1.16
Cell cycles in two cell lines of human bladder carcinoma. Tohoku J Exp Med (1977) 1.14
The role of surgery in the potentially curative treatment of bladder carcinoma. Cancer Res (1977) 1.13
Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J Urol (1985) 1.12
Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol (2000) 1.10
Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes. Diabet Med (2008) 1.09
Effects of 12-O-tetradecanoyl-phorbol-13-acetate on cell proliferation and Epstein-Barr virus DNA replication. Virology (1982) 1.08
Cytokine release from osteoblasts in response to ultrasound stimulation. Biomaterials (2003) 1.08
Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus. Antimicrob Agents Chemother (1985) 1.07
Detection of human papillomavirus DNA in colorectal carcinomas by polymerase chain reaction. Gut (1995) 1.05
Influence of dye and protein location on photosensitization of the plasma membrane. Biochim Biophys Acta (1994) 1.05
Effect of acupuncture on cardiopulmonary function. Chin Med J (Engl) (1996) 1.04
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
A comparative study of trabecular bone properties in the spine and femur using high resolution MRI and CT. J Bone Miner Res (1998) 1.03
Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. Invest Urol (1978) 1.03
Chemotherapy programs of the National Prostatic Cancer Project (NPCP). Cancer (1980) 1.03
Bladder carcinoma as a systemic disease. Cancer (1979) 1.03
Invasive bladder cancer: tumor configuration, lymphatic invasion and survival. J Urol (1983) 1.02
Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. N Engl J Med (1987) 1.02
Metabolic activation of 9([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human lymphoblastoid cell lines infected with Epstein-Barr virus. J Virol (1986) 1.00
Octopus S-crystallins with endogenous glutathione S-transferase (GST) activity: sequence comparison and evolutionary relationships with authentic GST enzymes. Biochem J (1995) 1.00
Acyclovir and Epstein-Barr virus infection. J Antimicrob Chemother (1983) 1.00
Non-surgical retrieval of intravascular foreign body: experience of 12 cases. Eur J Radiol (1994) 1.00
A randomized controlled trial on the treatment for acute partial ischemic stroke with acupuncture. Neuroepidemiology (1993) 0.99
Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging. J Nucl Med (2001) 0.99
Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells. J Virol (1987) 0.99
Radiation therapy for localized prostate carcinoma: experience at the Massachusetts General Hospital (1973-1981). NCI Monogr (1988) 0.98
Transitional cell carcinoma of renal pelvis. Urology (1982) 0.98
Testicular tumors: delay in diagnosis and influence on survival. Am Fam Physician (1984) 0.97
The determination of dissociation constants for substance P and substance P analogues in the guinea pig ileum by pharmacological procedures. Mol Pharmacol (1983) 0.97
Purification and characterization of mouse kidney beta-glucuronidase. J Biol Chem (1975) 0.96
Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema. Br J Pharmacol (2007) 0.96
Activation of latent Epstein-Barr virus genomes: selective stimulation of synthesis of chromosomal proteins by a tumor promoter. J Virol (1983) 0.95
Function of human Fc gamma RIIA and Fc gamma RIIIB. Semin Immunol (1995) 0.95
Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA (1987) 0.95
A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study. Cancer (1983) 0.94
MRI compatibility and visibility assessment of implantable medical devices. J Magn Reson Imaging (1999) 0.94
A microprocessor-based noninvasive arterial pulse wave analyzer. IEEE Trans Biomed Eng (1985) 0.94
Immunospecificity to non-histone chromosomal proteins of anti-chromatin antibodies. Nat New Biol (1973) 0.94
The heterogeneity of invasive bladder carcinoma and different responses to treatment. J Urol (1980) 0.94
Induction of replication of Epstein-Barr virus DNA by 12-O-tetradecanoyl-phorbol-13-acetate. II. Inhibition by retinoic acid and 9-(2-hydroxyethoxymethyl) guanine. Virology (1981) 0.94
T-cell malignant lymphoma with conjunctival involvement. Am J Ophthalmol (1998) 0.94
Identification of vessels by lectin-immunoperoxidase staining of endothelium: possible applications in urogenital malignancies. J Urol (1984) 0.93
Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens. Cancer Res (1985) 0.93
Effect of 514.5-nm argon ion laser radiation on hematoporphyrin derivative-treated bladder tumor cells in vitro and in vivo. J Natl Cancer Inst (1985) 0.93
Anisotropy of the elastic modulus of trabecular bone specimens from different anatomical locations. Med Eng Phys (1998) 0.93
Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection. J Neurosurg (1986) 0.92
The effect of intravesical thio-tepa on normal and tumor urothelium. J Urol (1978) 0.92
Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo. J Med Chem (1997) 0.92
Parkinsonism as an initial manifestation of brain tumor. Zhonghua Yi Xue Za Zhi (Taipei) (2000) 0.92
Magnetic necklace: its therapeutic effectiveness on neck and shoulder pain. Arch Phys Med Rehabil (1982) 0.91
Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes. Oncogene (2000) 0.91
Androgen responsiveness of stromal cells of the human prostate: regulation of cell proliferation and keratinocyte growth factor by androgen. J Urol (1998) 0.91
Brachial plexus neuropathy associated with scrub typhus: report of a case. J Formos Med Assoc (1992) 0.90
Recent clinical experience with left heart bypass using a centrifugal pump for repair of traumatic aortic transection. Ann Surg (1999) 0.90
Nodal involvement as a prognostic indicator in patients with prostatic carcinoma. J Urol (1980) 0.90
Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms. Cancer (1983) 0.90
Synovial activation of chondrocytes: evidence for complex cytokine interactions. Agents Actions (1991) 0.90
Zinc deficiency in reproducing gilts fed a diet high in calcium and its effect on tissue zinc and blood serum alkaline phosphatase. J Anim Sci (1967) 0.90